Pauline le Vu

Pauline Le Vu has a diverse work experience in the field of research and development. Pauline has worked as a Principal Scientist at Abzena since November 2023, previously serving as a Senior Scientist from January 2022 to November 2023. Before their role at Abzena, they were a Research Fellow at the University of Southampton from March 2020 to August 2021. Pauline also worked as a PHD Student at Nottingham Trent University from October 2015 to February 2020. Pauline has held various trainee positions at different institutions, including Institut Pasteur Lille, INSERM UMR 1011 Nuclear receptors, cardiovascular diseases and diabetes, Gustave Roussy, Laboratoire d'Immuno-monitoring en Oncologie, University of Queensland, Diamantina Institute, Auto-Immune Diseases Team, University of Leicester, Institute for Lung Health, Nottingham Trent University, John Van Geest Cancer Research Centre, and INSERM UMR785, Hopital Paul Brousse, Centre Hépato-biliaire between 2010 and 2015.

Pauline Le Vu completed their education in the following institutions and degrees:

- Nottingham Trent University (2015-2019): Doctor of Philosophy (Ph.D.) in Cancer Immunology.

- Paris-Sud University (Paris XI) (2013-2014): Master's degree in Immunology.

- Université Paris-Est Créteil (UPEC) (2011-2013): Master's degree in Health Biology, with a focus on Immunology and Cancer Biology.

- Université Paris-Est Créteil (UPEC) (2010-2011): Three-year degree in Biology, specializing in Molecular, Cellular Biology, and Physiology.

- Université Paris-Est Créteil (UPEC) (2008-2010): DUT (2-year degree) in Biological Engineering, with a specialization in Biological and Biochemical Analysis.

- Lycée Grégor Mendel (2005-2008): Baccalaureat in Laboratory Sciences and Techniques, with a focus on Biology and Biochemistry.

In addition to their academic achievements, Pauline Le Vu obtained the certification "Diplôme d'expérimentation animale niveau I "Conception et réalisation de procédures expérimentales"" from Ecole Nationale Vétérinaire d'Alfort in 2014.